NIH R01 R21 (small business / SBIR adjacent)

NIH R01 R21 (small business / SBIR adjacent) groups NIH activity-code opportunities for biomedical and life-science work under the National Institutes of Health. The route sits in the U.S. research-funding system and is used for projects that are early enough for research support but mature enough to sit above a pure concept pitch. It follows NIH's parent-announcement machinery rather than a single institute-specific competition. Awards run from $275,000 to $500,000, with a median actual size of $375,000. The cycle is multiple times per year, and the project window spans roughly TRL 2 through TRL 7. Eligible applicants include U.S. institutions and for-profits where the relevant NOFO allows them, while individuals are excluded and the same scope cannot be stacked twice. This route suits teams with a clearly defined biomedical problem, a credible research plan, and enough institutional backing to move through NIH peer review. The most useful applications are tightly scoped, technically specific, and aligned to the activity code's intended scope. For applicants, the practical test is whether the work belongs in NIH's research lane and can survive the review expectations attached to the particular announcement.

No upcoming rounds verified. Cadence: Multiple per year.